Q2 EPS Estimate for Jasper Therapeutics Lifted by Analyst
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Free Report) – Equities researchers at HC Wainwright boosted their Q2 2025 earnings per share (EPS) estimates for Jasper Therapeutics in a research note issued on Tuesday, May 13th. HC Wainwright analyst E. Bodnar now anticipates that the company will post earnings of ($1.53) per share for the quarter, up […]
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Free Report) – Equities researchers at HC Wainwright boosted their Q2 2025 earnings per share (EPS) estimates for Jasper Therapeutics in a research note issued on Tuesday, May 13th. HC Wainwright analyst E. Bodnar now anticipates that the company will post earnings of ($1.53) per share for the quarter, up […]
